AJO LP’s Alnylam Pharmaceuticals ALNY Stock Holding History

AJO LP’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-29,273	Closed	-$4.33M	–	683
2020 Q2	$4.33M	Buy	29,273 +11,235	+62%	+$1.51M	0.04%	289
2020 Q1	$1.96M	Buy	+18,038	New	+$2.08M	0.02%	343

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AJO LP's ALNY Position: Q3 2020 in Review

AJO LP sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2020, closing a stake of 29,273 shares — an estimated $4.33M sold.

AJO LP first reported a position in ALNY in Q1 2020 and held it in 2 quarters. The position peaked at $4.33M in Q2 2020. 356 funds tracked by Wall St. Rank hold ALNY as of Q3 2020.

AJO LP reported no remaining Alnylam Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
AJO LP sold 29,273 Alnylam Pharmaceuticals shares in Q3 2020, an estimated $4.33M.
AJO LP first reported a position in Alnylam Pharmaceuticals in Q1 2020 and held it in 2 quarters.
AJO LP's Alnylam Pharmaceuticals position peaked at $4.33M in Q2 2020.
356 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2020.

Based on AJO LP's 13F filing for Q3 2020, filed 10 Nov 2020.